Events

Successful BIORIMA Consortium Meeting held in Rome, Italy.

The BIORIMA project was part of the joint NanoSafety Cluster booth at the 9th edition of EuroNanoForum.

In the light of increasing regulatory demands on the use of medical devices (MD) and advanced therapeutic medicinal products (ATMP), the EU funded BIORIMA project has taken a lead in developing an integrated risk management framework for the safe handling of nano-biomaterials (NBM) used in these medical applications. For the first time, it will be possible to assess and manage various risks that may arise from manufacturing and use of these novel materials along their life cycle and beyond clinical risks.

22 - 27 March 2020, Venice, Italy

3 - 7 May 2020, Dublin, Ireland

7 - 10 July, Melbourne, Australia

6 - 9 September 2020, Copenhagen, Denmark

16 - 20 November 2020, Grenoble, France